Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Hyperbilirubinaemia neonatal
ADR ID BADD_A07298
ADR Hierarchy
09      Hepatobiliary disorders
09.01      Hepatic and hepatobiliary disorders
09.01.01      Cholestasis and jaundice
09.01.01.014      Hyperbilirubinaemia neonatal
14      Metabolism and nutrition disorders
14.11      Metabolism disorders NEC
14.11.01      Metabolic disorders NEC
14.11.01.038      Hyperbilirubinaemia neonatal
17      Nervous system disorders
17.13      Encephalopathies
17.13.01      Encephalopathies toxic and metabolic
17.13.01.009      Hyperbilirubinaemia neonatal
18      Pregnancy, puerperium and perinatal conditions
18.04      Neonatal and perinatal conditions
18.04.08      Neonatal hepatobiliary disorders
18.04.08.003      Hyperbilirubinaemia neonatal
Description Not Available
MedDRA Code 10020580
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Bilirubinaemia newborn | Bilirubinemia newborn | Hyperbilirubinaemia neonatal | Hyperbilirubinaemia newborn | Hyperbilirubinemia neonatal | Hyperbilirubinemia newborn
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00033Acetylsalicylic acid0.000055%
BADD_D00734Duloxetine0.000027%
BADD_D00981Gabapentin0.000010%
BADD_D01107Hydroxyprogesterone caproate-
BADD_D01236Labetalol0.000163%
BADD_D01243Lamotrigine0.000331%
BADD_D01617Ondansetron0.000021%
BADD_D01668Pantoprazole0.000016%
BADD_D01834Prednisone0.000009%
BADD_D01835Pregabalin0.000052%
BADD_D02010Sertraline0.000032%
BADD_D02464Fingolimod0.000241%
The 1th Page    1    Total 1 Pages